[HTML][HTML] Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases

Q Zhao, H Ren, Z Han - Journal of cellular immunotherapy, 2016 - Elsevier
Mesenchymal stem cells (MSCs) represent a heterogenous population of adult, fibroblast-
like multi-potent cells. MSCs have drawn much attention during the last decade in the field of …

Adipogenesis, osteogenesis, and chondrogenesis of human mesenchymal stem/stromal cells: a comparative transcriptome approach

AW Robert, BH Marcon, B Dallagiovanna… - Frontiers in cell and …, 2020 - frontiersin.org
Adipogenesis, osteogenesis and chondrogenesis of human mesenchymal stem/stromal
cells (MSC) are complex and highly regulated processes. Over the years, several studies …

Engineered marble-like bovine fat tissue for cultured meat

Y Zagury, I Ianovici, S Landau, N Lavon… - Communications …, 2022 - nature.com
Cultured meat can provide a sustainable and more ethical alternative to conventional meat.
Most of the research in this field has been focused on developing muscle tissue, as it is the …

Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells

JD Kretlow, YQ Jin, W Liu, WJ Zhang, TH Hong, G Zhou… - BMC cell biology, 2008 - Springer
Background Bone marrow-derived mesenchymal stem cells (BMSCs) are a widely
researched adult stem cell population capable of differentiation into various lineages …

Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells

M Zaim, S Karaman, G Cetin, S Isik - Annals of hematology, 2012 - Springer
Bone marrow-derived human mesenchymal stem cells (BM-hMSCs) represent a promising
cell-based therapy for a number of degenerative conditions. Many applications require cell …

Engineering robust and functional vascular networks in vivo with human adult and cord blood–derived progenitor cells

JM Melero-Martin, ME De Obaldia, SY Kang… - Circulation …, 2008 - Am Heart Assoc
The success of therapeutic vascularization and tissue engineering will rely on our ability to
create vascular networks using human cells that can be obtained readily, can be expanded …

Adipose tissue engineering for soft tissue regeneration

JH Choi, JM Gimble, K Lee, KG Marra… - … Engineering Part B …, 2010 - liebertpub.com
Current treatment modalities for soft tissue defects caused by various pathologies and
trauma include autologous grafting and commercially available fillers. However, these …

CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities

P Anderson, AB Carrillo-Gálvez, A García-Pérez… - PloS one, 2013 - journals.plos.org
Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a
promising therapy for regenerative medicine and autoimmunity. Both mouse and human …

Decellularized adipose tissue microcarriers as a dynamic culture platform for human adipose-derived stem/stromal cell expansion

C Yu, A Kornmuller, C Brown, T Hoare, LE Flynn - Biomaterials, 2017 - Elsevier
With the goal of designing a clinically-relevant expansion strategy for human adipose-
derived stem/stromal cells (ASCs), methods were developed to synthesize porous …

Vascularized adipose tissue engineering: moving towards soft tissue reconstruction

A Peirsman, HT Nguyen, M Van Waeyenberge… - …, 2023 - iopscience.iop.org
Soft tissue defects are a common clinical challenge mostly caused by trauma, congenital
anomalies and oncological surgery. Current soft tissue reconstruction options include …